F. Ricciardolo (Orbassano (TO), Italy), A. Sinha (Amsterdam, Netherlands)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Eosinophilic phenotype classification of patients with asthma and/or COPD in NOVELTY
D. Price (Aberdeen, United Kingdom), I. Pavord (Oxford, United Kingdom), K. Peres Da Costa (London, United Kingdom), A. Agustí (Barcelona, Spain), G. Anderson (Victoria, Australia), A. Bansal (Cambridge, United Kingdom), E. Bel (Amsterdam, Netherlands), M. Fagerås (Gothenburg, Sweden), R. Hughes (Cambridge, United Kingdom), H. Inoue (Kagoshima, Japan), G. Lassi (Cambridge, United Kingdom), J. Olaguibel (Pamplona, Spain), A. Papi (Ferrara, Italy), M. Rabahi (Goiânia, Brazil), H. Reddel (Sydney, Australia), A. Rendon (Nuevo León, Mexico), M. Van Den Berge (Groningen, Netherlands), H. Müllerová (Cambridge, United Kingdom)
|   |
Importance of type and degree of IgE sensitisation for defining fractional exhaled nitric oxide reference values
S. Zaigham (Malmö, Sweden), X. Zhou (Uppsala, Sweden), M. Molin (Uppsala, Sweden), A. Sjölander (Uppsala, Sweden), R. Movérare (Uppsala, Sweden), C. Janson (Uppsala, Sweden), A. Malinovschi (Uppsala, Sweden)
| |
Eosinophilic inflammation and muscle mass in chronic airway disease
E. Visser (Leeuwarden, Netherlands), K. De Jong (Leeuwarden, Netherlands), T. Van Zutphen (Leeuwarden, Netherlands), H. Kerstjens (Groningen, Netherlands), A. Ten Brinke (Leeuwarden, Netherlands)
| |
Phenotyping asthmatic outpatients by cluster analysis in a real-world setting
F. Bertolini (Orbassano, Italy), G. Ciprandi (Genova, Italy), F. Gallo (Genova, Italy), E. Riccardi (Orbassano, Italy), V. Carriero (Orbassano, Italy), F. Ricciardolo (Orbassano, Italy)
| |
Stability of blood eosinophils over time in patients with asthma
K. Verhamme (Rotterdam, Netherlands), M. De Ridder (Rotterdam, Netherlands), D. Webb (London, United Kingdom), D. D. Prieto-Alhambra (Oxford, United Kingdom), P. Rijnbeek (Rotterdam, Netherlands), L. Pedersen (Aarhus, Denmark), M. Van Dyke ( Upper Providence, United States of America), G. Brusselle ( Ghent, Belgium)
| |
The role of education in the comparison between self and physician-administered asthma control test scores.
S. Dragonieri (Bari (BA), Italy), E. Scisci (Bari (BA), Italy), E. Capozza (Bari (BA), Italy), F. Barratta (Bari (BA), Italy), M. De Candia (Bari (BA), Italy), G. Carpagnano (Bari (BA), Italy)
| |
Features of FeNO-high asthma phenotype
F. Bertolini (Orbassano, Italy), A. Sprio (Orbassano, Italy), E. Riccardi (Orbassano, Italy), A. Baroso (Orbassano, Italy), V. Carriero (Orbassano, Italy), F. Ricciardolo (Orbassano, Italy)
| |
Comparison between long- and short-term participants in a Disease Management Program (DMP) Bronchial Asthma in North Rhine Westphalia in Germany
A. Weber (Cologne, Germany), S. Groos (Cologne, Germany), J. Kretschmann (Cologne, Germany), C. Macare (Cologne, Germany), H. Bernd (Cologne, Germany)
| |
High prevalence of mild asthma among asthmatics visiting emergency department (ED)
Z. Barmparessou (Athens, Greece), A. Korkontzelou (Athens, Greece), M. Ioannou (Athens, Greece), N. Vichos (Athens, Greece), M. Gkotsina (Athens, Greece), K. Mprinia (Athens, Greece), V. Saltagianni (Athens, Greece), T. Giannakas (Athens, Greece), V. Giannakoulis (Athens, Greece), N. Athanasiou (Athens, Greece), A. Antonoglou (Athens, Greece), S. Gida (Trikala, Greece), S. Kakavas (Athens, Greece), G. Boulbasakos (Athens, Greece), S. Pappa (London, United Kingdom), E. Zervas (Patra, Greece), P. Katsaounou (Athens, Greece)
| |
Assessing the Asthma Impairment and Risk Questionnaire’s ability to predict exacerbations
D. Beuther (Denver, United States of America), K. Murphy (Boys Town, United States of America), R. Zeiger (Pasadena, United States of America), R. Wise (Baltimore, United States of America), W. Mccann (Asheville, United States of America), J. Reibman (New York, United States of America), M. George (New York, United States of America), I. Gilbert (Wilmington, United States of America), J. Eudicone (Wilmington, United States of America), . Gandhi (Wilmington, United States of America), . Ross (Bethesda, United States of America), K. Coyne (Bethesda, United States of America), B. Chipps (Sacramento, United States of America)
| |
Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes
M. Ghanizada (Copenhagen, Denmark), A. Jabarkhil (Copenhagen, Denmark), S. Hansen (Copenhagen, Denmark), N. Dyhre-Petersen (Copenhagen, Denmark), C. Woehlk (Copenhagen, Denmark), M. Baastrup Søndergaard (Copenhagen, Denmark), T. Lapperre (Wilrijk, Belgium), C. Porsbjerg (Copenhagen, Denmark)
| |
Heterogeneity and time course of asthma exacerbations: data from AUSTRI
H. Reddel (Sydney, Australia), W. Busse (Madison, United States of America), K. Rabe (Grosshansdorf,, Germany), B. Aggarwal (Singapore, Singapore), R. Forth (Durham, United States of America), I. Boucot (Brentford, United Kingdom), I. Raphiou (Durham, United States of America), D. Stempel (San Francisco, United States of America)
| |
Burden of asthma by treatment step in the French CONSTANCES general population cohort
N. Roche (Paris, France), R. Nadif (Villejuif, France), C. Fabry-Vendrand (Courbevoie, France), L. Pillot (Courbevoie, France), G. Thabut (Courbevoie, France), C. Teissier (Bourg la Reine, France), S. Bouée (Bourg la Reine, France), M. Zins (Villejuif, France), M. Goldberg (Villejuif, France)
| |
Asthma management - opinion of family doctors and patient’s view
A. Demchuk (Vinnytsia, Ukraine), Y. Mostovoy (Vinnytsia, Ukraine), T. Konstantynovych (Vinnytsia, Ukraine)
| |
A pictorial asthma action plan to improve asthma control in Malaysian adults
S. Shariff Ghazali (UPM Serdang, Selangor, Malaysia), P. Lee (UPM Serdang, Selangor, Malaysia), A. Cheong (UPM Serdang, Selangor, Malaysia), H. Salim (UPM Serdang, Selangor, Malaysia), N. Hussein (Kuala Lumpur, Malaysia), H. Pinnock (Edinburgh, United Kingdom), S. Liew (Kuala Lumpur, Malaysia), N. Hanafi (Kuala Lumpur, Malaysia), C. Ng (Kuala Lumpur, Malaysia), R. Ramli (Kuala Lumpur, Malaysia), A. Mohd Ahad (Port Dickson, Malaysia), B. Ho (Klang, Malaysia), S. Mohamed Isa (Klang, Malaysia), R. Parker (Edinburgh, United Kingdom), A. Stoddart (Edinburgh, United Kingdom), Y. Pang (Kuala Lumpur, Malaysia), K. Chinna (Kuala Lumpur, Malaysia), E. Khoo (Kuala Lumpur, Malaysia)
| |
Methotrexate treatment in recent onset RA does not change the NO dynamics of the lung
M. Högman (Uppsala, Sweden), A. Lind (Gävle, Sweden), A. Larsson (Uppsala, Sweden), J. Rönnelid (Uppsala, Sweden), T. Weitoft (Gävle, Sweden)
| |
LSC - 2021 - Effects of mild to moderate asthma in pregnancy on the wellbeing of mother and newborn; A case control study from Sri Lanka.
Y. Duminda, T. Anuththara (tanuththara@gmail.com / University of Peradeniya,Kandy), G. Jayalath (gihani.jayalath2@gmail.com / University of Peradeniya,Kandy), F. Rafsanjani (jani.rafsan@gmail.com / University of Peradeniya,Kandy), S. Priyankara (tmspriyankara@gmail.com / National Institute of Fundamental Studies,Kandy), G. Bowatta (gbowatte@gmail.com / University of Peradeniya,Kandy), C. Rathnayake (chathura.ratnayake@gmail.com / University of Peradeniya,Kandy), S. Dharmarathne (samath.dharmaratne@mbbs.md / University of Peradeniya,Kandy), S. Dharmage (s.dharmage@unimelb.edu.au / University of Melbourne,Melbourne)
| |
Late Breaking Abstract - Small airways dysfunction predicts asthma control and exacerbations: Longitudinal Data from ATLANTIS Study
M. Kraft (Tucson, United States of America), M. Richardson (Leichester, United Kingdom), B. Hallmark (Tucson, United States of America), D. Billheimer (Tucson, United States of America), M. Van Den Berge (Groningen, Netherlands), L. Fabbri (Ferrara, Italy), T. Van Der Molen (Groningen, Netherlands), G. Nicolini (Parma, Italy), A. Papi (Ferrara, Italy), K. Rabe (Kiel, Germany), D. Singh (Manchester, United Kingdom), C. Brightling (Leichester, United Kingdom), S. Siddiqui (Leichester, United Kingdom)
| |
Late Breaking Abstract - Adrenal function improvement after oral corticosteroid reduction in benralizumab-treated severe eosinophilic asthma: PONENTE maintenance phase
M. Gurnell (Cambridge, United Kingdom), L. Heaney (Belfast, United Kingdom), A. Menzies-Gow (London, United Kingdom), J. Corren (Los Angeles, United States of America), E. Bel (Amsterdam, Netherlands), J. Maspero (Buenos Aires, Argentina), T. Harrison (Nottingham , United Kingdom), D. Jackson (London, United Kingdom), D. Price (Singapore, Singapore), N. Lugogo (Ann Arbor, United States of America), A. Burden (Cambridge, United Kingdom), A. De Giorgio-Miller (Luton, United Kingdom), K. Padilla (Durham, United States of America), U. Martin (Gaithersburg, United States of America), E. Garcia Gil (Barcelona, Spain), J. Kreindler (Wilmington, United States of America)
| |
Late Breaking Abstract - The SF-36 quality of life scales are sensitive measures of lung function decline
J. Kirkeleit (Bergen, Norway), T. Riise (Bergen, Norway), D. Jarvis (London, United Kingdom), F. Real (Bergen, Norway), C. Janson (Uppsala, Sweden), B. Leynaert* (Paris, France), C. Svanes* (Bergen, Norway)
| |